共 45 条
- [1] Chahar D, Sonkar GK, Singh S, Sonkar SK, Ahmad MK., Unraveling epigenetic signatures for early detection of diabetes nephropathy in type 2 diabetes: A case-control investigation, Biomed Biotech Res J (BBRS), 8, pp. 108-116, (2024)
- [2] Ilango S, Paital B, Jayachandran P, Padma PR, Nirmaladevi R., Epigenetic alterations in cancer, Front Biosci (Landmark Ed), 25, pp. 1058-1109, (2020)
- [3] Yang Y, Zhang M, Wang Y., The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy, J Natl Cancer Cent, 2, pp. 277-290, (2022)
- [4] Hassell KN., Histone deacetylases and their inhibitors in cancer epigenetics, Diseases, 7, (2019)
- [5] Liao B, Sun Q, Yuan Y, Yin Y, Qiao J, Jiang P., Histone deacetylase inhibitor MGCD0103 causes cell cycle arrest, apoptosis, and autophagy in liver cancer cells, J Cancer, 11, pp. 1915-1926, (2020)
- [6] Hanisch D, Krumm A, Diehl T, Stork CM, Dejung M, Butter F, Et al., Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression, Cell Death Dis, 13, (2022)
- [7] Kumar A, Emdad L, Fisher PB, Das SK., Targeting epigenetic regulation for cancer therapy using small molecule inhibitors, Adv Cancer Res, 158, pp. 73-161, (2023)
- [8] Li W, Sun Z., Mechanism of action for HDAC inhibitors-insights from omics approaches, Int J Mol Sci, 20, (2019)
- [9] Wang K, Tang R, Wang S, Xiong Y, Wang W, Chen G, Et al., Isoform-selective HDAC inhibitor mocetinostat (MGCD0103) alleviates myocardial ischemia/reperfusion injury via mitochondrial protection through the HDACs/CREB/PGC-1α signaling pathway, J Cardiovasc Pharmacol, 79, pp. 217-228, (2022)
- [10] Schulpen E., Candidate Compounds for the Chemoprevention of Hereditary Diffuse Gastric Cancer, (2019)